BAALC-Expressing Earlier Leukemic Progenitors: Crucial Role in AML Relapses with Evaluation of Their Treatment and Prevention Efficacy
Insights in Blood Disorders · 2022
DOI: 10.33425/2771-9073.1001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Insights in Blood Disorders, 2022. Verfasst von Mamaev NN und 3 weiteren Autor:innen.
Abstract (Originalsprache)
A new concept of acute myeloid leukemia (AML) relapses is proposed which is linked with direct participation of BAALC-expressing earlier leukemic progenitors (ELP). The latter may be studied effectively by means of real-time quantitative polymerase chain reaction (RT-qPCR). Recent findings in support of this conception and ongoing prospective studies in the field are shortly discussed.
Zitieren
APA
NN, M., AI, S., MM, K., & TL, G. (2022). BAALC-Expressing Earlier Leukemic Progenitors: Crucial Role in AML Relapses with Evaluation of Their Treatment and Prevention Efficacy. Insights in Blood Disorders. https://doi.org/10.33425/2771-9073.1001
Vancouver
NN M, AI S, MM K, TL G. BAALC-Expressing Earlier Leukemic Progenitors: Crucial Role in AML Relapses with Evaluation of Their Treatment and Prevention Efficacy. Insights in Blood Disorders. 2022. doi:10.33425/2771-9073.1001
BibTeX
@article{NN2022,
author = {NN, Mamaev and AI, Shakirova and MM, Kanunnikov and TL, Gindina},
title = {BAALC-Expressing Earlier Leukemic Progenitors: Crucial Role in AML Relapses with Evaluation of Their Treatment and Prevention Efficacy},
journal = {Insights in Blood Disorders},
year = {2022},
doi = {10.33425/2771-9073.1001}
}
EUVIMED